|
|
Efficacy and safety of low temperature plasma ablation in treating elderly postherpetic neuralgia |
YANG Liqiang1 NI Jiaxiang1 LI Xiaolin1 HE Liangliang1 DOU Zhi1 SUN Dongguang2 PANG Haitao3 |
1.Department of Pain Management, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;
2.Department of Pain Management, the First Affiliated Hospital of Harbin Medical University, Heilongjiang Province, Harbin 150010, China;
3.Department of Anesthesiology, Traditional Chinese Medicine Hospital of Beijing Tongzhou District, Beijing 101100, China |
|
|
Abstract Objective To compare the clinical efficacy of radiofrequency nerve thermocoagulation and low temperature plasma ablation and to investigate the efficacy and safety of low temperature plasma ablation in treating elderly postherpetic neuralgia. Methods From May 2014 to May 2017, clinical data of 40 elderly patients with postherpetic neuralgia treated in Xuanwu Hospital, Capital Medical University was retrospectively analyzed, they were divided into radiofrequency nerve thermocoagulation (Group A) and low temperature plasma ablation (Group B) according to the treatment method, with 20 cases in each group. The visual analogue scores (VAS) of patients in the two groups were recorded before and 1 d, 1 month and 6 months after surgery; the life satisfaction index B table (LSI-B) scores of patients in the two groups were recorded before and 1 month after surgery; the postoperative complications after surgery of patients in the two groups were recorded. Results Compared with Group A, the VAS score of Group B was significantly lower at 1 d, 1 month and 6 months after surgery, with statistical significance (P < 0.05), and the life satisfaction scores of Group B were higher at 1 month after surgery, with statistical significance (P < 0.05). There were no postoperative complications occurred in Group B, but 8 patients with numbness in Group A. Conclusion Compared with radiofrequency nerve thermocoagulation, low temperature plasma ablation is safer and more effective in the treatment of elderly postherpetic neuralgia patients and has higher life satisfaction.
|
|
|
|
|
[1] Bowsher D. Post-herpetic neuralgia in older patients. Incidence and optimal treatment [J]. Drugs Aging,1994,5(6):411-418.
[2] Kost RG,Straus SE. Postherpetic neuralgia-pathogenesis,treatment,and prevention [J]. N Engl J Med,1996,335(1):32-42.
[3] 何荣芝,高崇荣.带状疱疹后神经痛的研究进展[J].中国疼痛医学杂志,2002,8(2):105-107.
[4] Jung BF,Johnson RW,Griffin DRJ,et al. Risk factors for postherpetic neuralgia in patients with herpes zoster [J]. Neurol,2004,62(9):1545-1551.
[5] 何亮亮,倪家骧.盘源性疼痛研究进展[J].中国全科医学,2017,20(26):3309-3313.
[6] Breivik H. Fifty years on the Visual Analogue Scale (VAS) for pain-intensity is still good for acute pain. But multidimensional assessment is needed for chronic pain [J]. Scand J Pain,2016,11:150-152.
[7] 王国林,王子千,王家双.中枢与周围神经痛治疗学[M].北京:人民军医出版社,2003:321.
[8] Jensen TS,Baron R,Haanp?觔¤?魨¤ M,et al. A new definition of neuropathic pain [J]. Pain,2011,152(10):2204-2205.
[9] Osent L. Long term efficacy of prebalin in patients with postherpetic neuralgia [J]. Pain J,2010,2(23):3-6.
[10] Jeon YH. Spinal cord stimulation in pain management:a review [J]. Korean J Pain,2012,25(3):143-150.
[11] Kim HJ,Ahn HS,Lee JY,et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster:a systematic review and meta-analysis [J]. Korean Pain J,2017,30(1):3-17.
[12] Hwang SY,Jefferson N,Mohorikar A,et al. Radiofrequency coblation of congenital nasopharyngeal teratoma:a novel technique [J]. Case Rep Otolaryngol,2015,2015:634958.
[13] Bekara F,Chaput B,Teot L,et al. Coblation Therapy in the Management of Chronic Wounds [J]. Plast Reconstr Surg,2017,139(4):1026e-1028e.
[14] Young MK,Wood M,Jean-Noel N. Postherpetic neuralgia in older adults:culture,quality of life,and the use of alternative/complementary therapies [J]. Holist Nurs Pract,2007,21(3):124-134.
[15] Petersen KL,Rice FL,Farhadi M,et al. Natural history of cutaneous innervation following herpes zoster [J]. Pain,2010,150(1):75-82.
[16] Dworkin RH,Panarites CJ,Armstrong EP,et al. Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations? [J]. Pain,2012,153(4):869-875.
[17] Hart RP,Martelli MF,Zasler ND. Chronic pain and neuropsychological functioning [J]. Neuropsychol Rev,2000, 10(3):131-149.
[18] Ma K,Zhou QH,Xu YM,et al. Peripheral nerve adjustment for postherpetic neuralgia:a randomized,controlled clinical study [J]. Pain Med,2013,14(12):1944-1953.
[19] He L,Tang Y,Li X,et al. Efficacy of coblation technology in treating cervical discogenic upper back pain [J]. Medicine(Baltimore),2015,94(20):e858.
[20] Srinivas N,Patricia MF. Diagnosing and managing postherpetic neuralgia [J]. Drugs Aging,2012,29(11):863-869.
[21] Salcido RS. Postherpetic neuralgia:the stealth attacker [J]. Adv Skin Wound Care,2012,25(6):246.
[22] Geha PY,Baliki MN,Wang X,et al. Brain dynamics for perception of tactile allodynia (touch-induced pain) in postherpetic neuralgia [J]. Pain,2008,138(3):641-656.
[23] Geha PY,Baliki MN,Chialvo DR,et al. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy [J]. Pain,2007,128(1-2):88-100.
[24] Malec-Milewska M,Sekowska A,Koleda I,et al. Sympathetic nerve blocks for the management of postherpetic neuralgia-19 years of pain clinic experience [J]. Anaesthesiol Intensive Ther,2014,46(4):255-261. |
|
|
|